The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma
Background. Pancreatic adenocarcinoma (PAAD) has become the major cause of cancer-related deaths globally. The m6A (N6-methyladenosine) alteration plays a crucial function in carcinogenesis and tumor progression. The role of genes related to m6A and their expression level in pancreatic cancer is not...
Guardado en:
Autores principales: | Fei Li, Ping Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f4a5457a23474b929c77ba4e93712705 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Wearable devices can predict the outcome of standardized 6-minute walk tests in heart disease
por: Charlotte Schubert, et al.
Publicado: (2020) -
Identification of Potential Osteoporosis miRNA Biomarkers Using Bioinformatics Approaches
por: Wei Lu, et al.
Publicado: (2021) -
Digital biomarker of mental fatigue
por: Vincent Wen-Sheng Tseng, et al.
Publicado: (2021) -
ANLN Regulated by miR-30a-5p Mediates Malignant Progression of Lung Adenocarcinoma
por: Feng Deng, et al.
Publicado: (2021) -
Deep Learning in Cancer Diagnosis and Prognosis Prediction: A Minireview on Challenges, Recent Trends, and Future Directions
por: Ahsan Bin Tufail, et al.
Publicado: (2021)